Pharmacovigilance is used to detect, assess, understand, and prevent the adverse effects of medications. The need for safety monitoring has evolved around unfortunate incidents in history, with deaths caused by anesthesia and congenital malformations from thalidomide use. Reports from adverse drug reactions (ADRs) are stored in a global database and can be used to evaluate the associations between various medications and associated ADRs. Clinicians play an important role in the recognition and reporting of ADRs to national pharmacovigilance centers (NPCs). The purpose of NPCs is to make the clinicians understand their functions, including the monitoring, investigation, and assessment of ADR reports, along with periodical benefit-risk assessments of medications via multiple sources. A case study on NPCs and the types of safety issues evaluated by them are provided to illustrate their role in medicine safety surveillance. ADR monitoring was also combined with vaccine safety surveillance approaches. Overall, this study will provide insights to clinicians on the importance of pharmacovigilance in maintaining patient safety with the proper use of medications.
Citations
Citations to this article as recorded by
Teaching approaches to delivering pharmacy law content to pre-registration pharmacy students: a global systematic scoping review Helen Ibrahim, Bandana Saini, Jessica Pace Currents in Pharmacy Teaching and Learning.2026; 18(1): 102507. CrossRef
A common drug, an uncommon reaction: The combination of amoxicillin-clavulanic acid induced acute allergic reaction with urticaria and angioedema—A case study Aruna Kale, Avinash Khairnar, Anil Pardeshi, Vaishali Agrawal, Shweta Bora Medical Reports.2026; 15: 100401. CrossRef
Long-Term Safety and Efficacy of Hybrid Cooperative Complexes of High- and Low-Molecular Weight Hyaluronic Acid to Improve Skin Laxity of the Inner Upper Arms: A Single-Arm Study Adele Sparavigna, Clara Cigni, Laura Tanzini, Roberto Lualdi, Franco Grimolizzi Plastic and Aesthetic Nursing.2026; 46(1): 37. CrossRef
Elevating Drug Safety Oversight: A Comprehensive Examination of Dynamic and Static Monitoring Systems across the United States, European Union, and India Deepika N, Robin George, Ravi Kumar Reddy Juturi, Baharul Islam Haidary, Prasiddhi Naik, Prakash Goudanavar Journal of Pharmaceutical Innovation.2026;[Epub] CrossRef
Analysis of literature-derived duplicate records in the FDA Adverse Event Reporting System (FAERS) database Weiru Han, Robert Morris, Kun Bu, Tianrui Zhu, Hong Huang, Feng Cheng Canadian Journal of Physiology and Pharmacology.2025; 103(2): 56. CrossRef
Leveraging Natural Language Processing and Machine Learning Methods for Adverse Drug Event Detection in Electronic Health/Medical Records: A Scoping Review Su Golder, Dongfang Xu, Karen O’Connor, Yunwen Wang, Mahak Batra, Graciela Gonzalez Hernandez Drug Safety.2025; 48(4): 321. CrossRef
Patient Experience Regarding Medication-Related Information Received in a Rural Private Polyclinic Setting in Vietnam Quang Loc Duyen Vo, Minh Trung Nguyen, Thi Ngoc Yen Dang, Thi Hong Dung Quach, Huynh Kim Ngoc Truong, Rebecca Susan Dewey, Thi Thu Tran, Van De Tran Journal of Patient Experience.2025;[Epub] CrossRef
Interações Fármaco-fármaco em Prescrições de Pacientes em Unidade de Terapia Intensiva Adulto em Hospital Público de Montes Claros Anna Lívia Lima, Kelly Cristiane Lopes, Esther Alves Marinho , Flávio Júnior Figueredo , Cecília Paiva Duarte , Viviane de Oliveira Vasconcelos, Izabella Mendes Lima , Thiago Santos Monção, Guilherme Henrique Azevedo dos Reis , Yves André Rodrigues Gomes Revista de Gestão e Secretariado.2025; 16(2): e4715. CrossRef
A critical comparison of pharmacovigilance reporting forms in six countries with the WHO-UMC recommendations (form of the form) Saurav Misra, Manmeet Kaur, Jayant Kumar Kairi Journal of Basic and Clinical Physiology and Pharmacology.2025; 36(4): 285. CrossRef
Glucocorticoid withdrawal syndrome: Disproportionality analysis of cases using VigiBase data Lütfi Mangal, Burcu Eda Arda, Hande Sipahi DARU Journal of Pharmaceutical Sciences.2025;[Epub] CrossRef
Enhancing Public Health with Pharmacovigilance: Tools, Strategies, and Impacts Sujitha Pandian, Yashvanthan Vinjmur Ragavan, Angeline Grace Pandian, Ajith Kumar Kumaraguru, Kiran Kartheep Subramanian Biomedical and Pharmacology Journal.2025; 18(2): 1147. CrossRef
Artificial Intelligence in Pharmacovigilance Dinesh Kumar, Amandeep Kaur, Shruti, Davender Kaur Current Computer Science.2025;[Epub] CrossRef
Excipients in pharmaceuticals: mechanisms of hypersensitivity and the role of global pharmacovigilance Ruba Malkawi, Lora Altahrawi Saudi Pharmaceutical Journal.2025;[Epub] CrossRef
Exploring pharmacovigilance awareness and attitudes among healthcare practitioners in Iraq: insights from a survey-based study Hussein Abdulmohsin Dabis, Ali Talib Hameed Jurnal Ners.2025; 20(1): 3. CrossRef
A PHARMACOVIGILANCE STUDY TO ASSESS THE EFFECT OF ADVERSE DRUG REACTION ON PEDIATRIC HEALTH ARULRAJA S, THILIP KUMAR GNANADURAI, SUBBULAKSHMI RAMASAMY Asian Journal of Pharmaceutical and Clinical Research.2025; : 87. CrossRef
Association between DPP4 inhibitor use and risk of skin cancer in type 2 diabetes: A real-world cohort study Zaryab Alam, Kevin T. Nguyen, Hamza Malick, Kyle C. Lauck, Stanislav N. Tolkachjov Journal of the American Academy of Dermatology.2025;[Epub] CrossRef
Assessment of adverse drug reactions encountered in primary care settings Ki Dong Ko Korean Journal of Family Medicine.2025; 46(6): 458. CrossRef
Pharmacovigilance and herbal medicines safety: a cross-sectional study of healthcare professionals’ knowledge, attitudes and practices in selected regions of Tanzania, 2021 Alambo K. Mssusa, Godeliver Kagashe, Sheila Maregesi, Lone Holst BMC Complementary Medicine and Therapies.2025;[Epub] CrossRef
Pharmacovigilance and adverse drug reaction reporting in primary, secondary, and tertiary healthcare: A review of practices, challenges, and recommendations Aleksandar Radlović, Elvis Mahmutović, Teodora Safiye Arhiv za farmaciju.2025; 75(6): 465. CrossRef
Safety of COVID-19 Vaccination During Pregnancy and Lactation: A VigiBase Analysis Dayeon Kang, Ahhyung Choi, Suneun Park, Seung-Ah Choe, Ju-Young Shin Journal of Korean Medical Science.2024;[Epub] CrossRef
Revolutionizing drug discovery: The impact of artificial intelligence on advancements in pharmacology and the pharmaceutical industry Seema Yadav, Abhishek Singh, Rishika Singhal, Jagat Pal Yadav Intelligent Pharmacy.2024; 2(3): 367. CrossRef
Drug Repurposing Using FDA Adverse Event Reporting System (FAERS)
Database Robert Morris, Rahinatu Ali, Feng Cheng Current Drug Targets.2024; 25(7): 454. CrossRef
Drug-Related Glomerular Phenotypes: A Global Pharmacovigilance Perspective Alexandre Baptista, Ana M. Macedo, Ana Marreiros, André Coelho, Mark A. Perazella Journal of Clinical Medicine.2024; 13(16): 4869. CrossRef
Postmarketing Surveillance: Review of Open Sources of Drug Safety Data E. V. Shubnikova Safety and Risk of Pharmacotherapy.2024; 12(3): 309. CrossRef
Exploring the community pharmacist’s knowledge, attitude, and practices regarding adverse drug reactions and its reporting in the United Arab Emirates: a survey-based cross-sectional study Javedh Shareef, Sathvik Belagodu Sridhar, Mullaicharam Bhupathyraaj, Atiqulla Shariff, Sabin Thomas Therapeutic Advances in Drug Safety.2024;[Epub] CrossRef
Pharmacovigilance: A Comprehensive Review of Drug Safety Monitoring Practices Aniket Anil Pawar, Aftab Imtiyaz Patel, Suhani Balu Jadhav, Harshavardhan T. Suryawanshi, Suhani Balu Jadhav International Journal of Advanced Research in Science, Communication and Technology.2024; : 314. CrossRef
Explicit potentially inappropriate medications criteria for older population in Asian countries: A systematic review Chee Tao Chang, Siew Li Teoh, Philip Rajan, Shaun Wen Huey Lee Research in Social and Administrative Pharmacy.2023; 19(8): 1146. CrossRef
A Real-World Data Driven Pharmacovigilance Investigation on Drug-Induced Arrhythmia Using KAERS DB, a Korean Nationwide Adverse Drug Reporting System Chaerin Go, Semi Kim, Yujin Kim, Yongjun Sunwoo, Sae Hyun Eom, Jiseong Yun, Sooyoung Shin, Yeo Jin Choi Pharmaceuticals.2023; 16(11): 1612. CrossRef
First
Prev
